WAY
$24.75
Waystar Holding Corp.
Intraday
Recent News
This Investor Is Betting $16 Million on a Software Stock Down 17% This Past Year. Here's What to Know
Specializing in AI-powered cloud platforms, NICE delivers enterprise solutions for customer experience, analytics, and compliance worldwide.
Waystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter
Waystar delivers cloud-based software to streamline healthcare payments and revenue cycle management for providers nationwide.
Alphabet Inc. (GOOG) Announced Expanded Partnership Between Waystar and Google Cloud
Alphabet Inc. (NASDAQ:GOOG) is one of the top stocks that will make you rich in 10 years. Alphabet Inc. (NASDAQ:GOOG) announced on March 5 an expanded collaboration between Waystar and Google Cloud, aimed at accelerating its agentic AI capabilities and advancing the industry to an autonomous revenue cycle. Waystar is a provider of leading healthcare […]
How Investors Are Reacting To Waystar Holding (WAY) Deepening Its Agentic AI Push With Google Cloud
On March 5, 2026, Waystar announced an expanded collaboration with Google Cloud to integrate Gemini models and data infrastructure into its AI-powered healthcare revenue cycle platform, aiming to support more autonomous, hyperscale deployment across complex billing and claims workflows. This next phase unites financial and clinical intelligence drawn from billions of transactions, opening new agentic AI use cases that could reshape how providers manage patient encounters and the full claims...
Is It Time To Reconsider Waystar Holding (WAY) After Healthcare Tech Sentiment Shift?
If you are wondering whether Waystar Holding's share price still reflects its underlying business, you are not alone. That is exactly what this article will unpack. The stock last closed at US$25.71, with returns of 0.2% over 7 days, 5.8% over 30 days, and a year to date return of an 18.0% decline alongside a 31.3% decline over the past year. Recent news flow around Waystar has focused on its position in healthcare technology and how investors are weighing that story against the share price...